Minwan Wu
Durham University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Minwan Wu.
Nucleosides, Nucleotides & Nucleic Acids | 2006
Pravin L. Kotian; V. Satish Kumar; Tsu-Hsing Lin; Yahya El-Kattan; Ajit Ghosh; Minwan Wu; Xiaogang Cheng; Shanta Bantia; Yarlagadda S. Babu; Pooran Chand
The introduction of versatile functional groups, allyl and ester, at the C-1 position of the acyclic chain in acyclic adenine nucleosides was achieved for the first time directly by alkylation of adenine and N6-protected adenine. Thus, the C-1′-substituted N9-adenine acyclic nucleoside, adenine-9-yl-pent-4-enoic acid ethyl ester (11), was prepared by direct alkylation of adenine with 2-bromopent-4-enoic acid ethyl ester (6), while the corresponding N7-regioisomer, 2-[6, (dimethylaminomethyleneamino)-purin-7-yl]-pent-4-enoic acid ethyl ester (10), was obtained in one step by the coupling of N,N-dimethyl-N′- (9H-purin-6-yl)-formamidine (9) with 2-bromopent-4-enoic acid ethyl ester (6). The functional groups, ester and allyl, were converted to the desired hydroxymethyl and hydroxyethyl groups, and subsequently to phosphonomethyl derivatives and corresponding pyrophosphorylphosphonates.
Nucleosides, Nucleotides & Nucleic Acids | 2005
Ajit Ghosh; Yahya El-Kattan; Minwan Wu; Tsu-Hsing Lin; Satish Vadlakonda; Pravin L. Kotian; Yarlagadda S. Babu; Pooran Chand
The appropriately protected C-1′-hydroxyethyl-3-hydroxypropyl-N9-adenine nucleoside was prepared from 1-pivaloyloxy-5-tert-butyldiphenylsilyloxy-3-pentanol and adenine through the Mitsunobu reaction. One of the terminal hydroxyls was converted to the phosphonomethoxy derivative and the prodrug.
Nucleosides, Nucleotides & Nucleic Acids | 2005
Minwan Wu; Yahya El-Kattan; Tsu-Hsing Lin; Ajit Ghosh; Satish Vadlakonda; Pravin L. Kotian; Yarlagadda S. Babu; Pooran Chand
A number of N 6 -substituted 9-[3-(phosphonomethoxy)propyl]adenine derivatives having hydroxymethyl at C-1′-position were prepared from the appropriate 6-chloroadenine derivative. The syntheses of the corresponding prodrugs of these compounds are also reported. These compounds showed poor activity against HCV in replicon assay.
Archive | 2002
Yarlagadda S. Babu; Pooran Chand; Yahya El-Kattan; Minwan Wu
Archive | 2010
Yarlagadda S. Babu; Pravin L. Kotian; V. Satish Kumar; Minwan Wu; Tsu-Hsing Lin
Archive | 2005
Yarlagadda S. Babu; Pooran Chand; Minwan Wu; Pravin L. Kotian; V. Satish Kumar; Tsu-Hsing Lin; Yahya El-Kattan; Ajit Ghosh
Archive | 2006
Yarlagadda S. Babu; Pooran Chand; Minwan Wu; Pravin L. Kotian; V. Satish Kumar; Tsu-Hsing Lin; Yahya El-Kattan; Ajit K. Ghosh
Archive | 2009
Yarlagadda S. Babu; Pooran Chand; Pravin L. Kotian; Minwan Wu; V. Satish Kumar
Archive | 2006
Pooran Chand; Minwan Wu; Pravin L. Kotian; Satish V. Kumar; Tsu-Hsing Lin
Archive | 2010
Yarlagadda S. Babu; Pravin L. Kotian; V. Satish Kumar; Minwan Wu; Tsu-Hsing Lin